These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23736127)

  • 1. Modulation of haemodynamics, endogeneous antioxidant enzymes, and pathophysiological changes by selective inhibition of angiotensin II type 1 receptors in pressureoverload rats.
    Moinuddin G; Inamdar MN; Kulkarni KS; Kulkarni C
    Cardiovasc J Afr; 2013 Apr; 24(3):58-65. PubMed ID: 23736127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of hemodynamics, endogenous antioxidant enzymes, and pathophysiological changes by Angiotensin-converting enzyme inhibitors in pressure-overload rats.
    Moinuddin G; Inamdar MN; Kulkarni KS; Kulkarni C
    Hellenic J Cardiol; 2011; 52(3):216-26. PubMed ID: 21642070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
    Awad AS
    Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?
    Dendorfer A; Dominiak P; Tempel K; Raasch W
    J Hypertens; 2005 Oct; 23(10):1861-7. PubMed ID: 16148610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy.
    Mukawa H; Toki Y; Miyazaki Y; Matsui H; Okumura K; Ito T
    Hypertens Res; 2003 Jan; 26(1):89-95. PubMed ID: 12661917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.
    Kusunoki H; Taniyama Y; Rakugi H; Morishita R
    J Am Heart Assoc; 2013 Apr; 2(2):e000103. PubMed ID: 23608606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R; Young SD; Strosberg AM
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
    Jones ES; Black MJ; Widdop RE
    J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
    Liang B; Leenen FH
    J Cardiovasc Pharmacol; 2008 May; 51(5):457-66. PubMed ID: 18418273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
    Baumann M; Janssen BJ; Hermans JJ; Peutz-Kootstra C; Witzke O; Smits JF; Struijker Boudier HA
    J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
    Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
    Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
    Sakuta T; Morita Y; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2010 May; 62(5):1319-28. PubMed ID: 20213806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats.
    Khaper N; Singal PK
    J Am Coll Cardiol; 2001 Apr; 37(5):1461-6. PubMed ID: 11300462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.